3-73062250-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018029.4(EBLN2):āc.169C>Gā(p.Pro57Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,599,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018029.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EBLN2 | NM_018029.4 | c.169C>G | p.Pro57Ala | missense_variant | 1/1 | ENST00000533473.1 | NP_060499.3 | |
PPP4R2 | NM_174907.4 | c.419+1190C>G | intron_variant | ENST00000356692.10 | NP_777567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EBLN2 | ENST00000533473.1 | c.169C>G | p.Pro57Ala | missense_variant | 1/1 | 6 | NM_018029.4 | ENSP00000432104.1 | ||
PPP4R2 | ENST00000356692.10 | c.419+1190C>G | intron_variant | 1 | NM_174907.4 | ENSP00000349124.5 |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 157AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000767 AC: 177AN: 230814Hom.: 0 AF XY: 0.000766 AC XY: 96AN XY: 125342
GnomAD4 exome AF: 0.00123 AC: 1778AN: 1446864Hom.: 1 Cov.: 62 AF XY: 0.00124 AC XY: 889AN XY: 719570
GnomAD4 genome AF: 0.00103 AC: 157AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000954 AC XY: 71AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.169C>G (p.P57A) alteration is located in exon 1 (coding exon 1) of the EBLN2 gene. This alteration results from a C to G substitution at nucleotide position 169, causing the proline (P) at amino acid position 57 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at